TCT 699: Mortality Risk in Patients Undergoing Endovascular Therapy for Lower Extremity: Artery Disease and Taking a Renin-Angiotensin-Aldosterone System Inhibitor: MIKENEKO Multi-Center Study

Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients:

• Consultant Fee/Honoraria/Speaker’s Bureau - Medtronic; W.L. Gore & Associates; Kaneka Medics; Terumo Medical Corporation; Bard Medical